United States. Securities and Exchange Commission
The Securities and Exchange Commission (SEC) has issued two recent enforcement actions that highlight its renewed focus on policing anti-money laundering (AML) compliance. The cases demonstrate the SEC's willingness to penalize individuals and entities that contribute to or cause AML failures, marking a significant shift in its approach
United States. Securities and Exchange Commission
Ambrx Biopharma Inc. has announced the termination of its American Depositary Shares (ADS) program, a move expected to simplify the company's ownership structure and reduce costs. The decision to terminate the ADS program, which will be effective upon the listing of NewCo's common stock on the
United States. Securities and Exchange Commission
CISCO SYSTEMS, INC. has submitted a current report (Form 8-K) to the UNITED STATES SECURITIES AND EXCHANGE COMMISSION on September 25, 2023, under the Securities Exchange Act of 1934. The report updates stakeholders on the proposed acquisition of Splunk Inc. by Cisco Systems, Inc., which was announced on September 21,
United States. Securities and Exchange Commission
Xcel Energy Inc. has made significant strides in transitioning to cleaner energy sources, with the Public Service Company of Colorado (PSCo), a wholly-owned subsidiary, filing a recommended portfolio of resources (Preferred Plan) with the Colorado Public Utilities Commission (CPUC) on September 18, 2023. The Preferred Plan aims to maximize the
United States. Securities and Exchange Commission
Xcel Energy Inc. and its subsidiary, Public Service Company of Colorado, have filed a report with the U.S. Securities and Exchange Commission outlining their plans to reduce greenhouse gas emissions and invest in renewable energy in Colorado. As part of the Colorado Resource Plan, Xcel Energy aims to exit
United States. Securities and Exchange Commission
Nektar Therapeutics, a Delaware-based biopharmaceutical company, has filed a Form 8-K with the U.S. Securities and Exchange Commission, announcing the termination of its global clinical development program evaluating bempegaldesleukin in combination with Opdivo (nivolumab). The decision to end the program was made jointly by Nektar and Bristol-Myers Squibb Company
United States. Securities and Exchange Commission
Centene Corporation has filed a Form 8-K with the U.S. Securities and Exchange Commission, reaffirming its 2023 Adjusted Diluted Earnings Per Share (EPS) annual guidance of at least $6.45. This announcement comes ahead of the company's presentation at the Wells Fargo 2023 Healthcare Conference on September
United States. Securities and Exchange Commission
Biotech Week reported on a U.S. Securities and Exchange Commission (SEC) filing by Amgen Inc. (Form 4) on August 11, 2023. The filing, which was posted by a News Reporter from Washington, D.C., pertains to the company's SIC code of 2836, Biological Products, and its headquarters
United States. Securities and Exchange Commission
Ginkgo Bioworks Holdings, Inc., a biotech company, has filed a Form 144 with the U.S. Securities and Exchange Commission (SEC), disclosing plans to sell restricted securities. The filing, which was made on August 14, 2023, indicates that the company intends to sell securities held by an affiliate in reliance
United States. Securities and Exchange Commission
Amgen Inc., a leading biopharmaceutical company, submitted a significant filing with the U.S. Securities and Exchange Commission (SEC) on August 3, 2023. The filing, identified by the SEC file number 0000318154-23-000049, contains 15 documents that provide crucial information about the company's recent events and corporate changes. As
United States. Securities and Exchange Commission
Moderna, Inc., a leading biotechnology company, has filed its Form 10-Q with the U.S. Securities and Exchange Commission (SEC) on August 3, 2023. The filing, which was reported by NewsRx journalists, includes unaudited financial statements and provides a continuing view of the company's financial position during the
United States. Securities and Exchange Commission
Xcel Energy's subsidiary, Southwestern Public Service Company, has filed an electric rate case with the Public Utility Commission of Texas (PUCT), seeking an increase in base rate revenue of $158 million, or a 14% impact to customer bills. The request is based on a return on equity (ROE)
